US$ 23.18
insurance companies that cover glp 1 drugs GLP-1 Weight Loss Drugs: Coverage Under Medicaid and Other Health Plans Insurance companies scrambling to support
Description
Another 2024 study found that people with breast cancer and type 2 diabetes taking GLP-1 drugs had fewer major cardiovascular problems (conditions related to heart and blood vessels) after receiving cardiotoxic breast cancer treatments such as anthracyclines and HER2 inhibitors, compared to people not taking GLP-1 drugs

In a recent MPTP PD mouse study, both exendin-4 and linagliptin reversed motor dysfunction, glial activation and dopaminergic neuronal death [52]
Change in HbA1c, eGFR, and cholesterol levels Biomarker values were assessed in posttreatment selected patients who were alive and had a measurement of the respective biomarker before and 312 months after treatment initiation, as the first available measurement within 12 months after treatment initiation

If SGLT2i are used in those with eGFR 8%, then the addition of these agents is less likely to cause hypoglycemia but the patient should be counselled about the potential for hypoglycemia

Competing interests LS has acted as paid reviewer for grant awarding bodies and as a paid consultant for health care companies

Molecular Nutrition & Food Research , 65(22), e2100071
